Suven Life Sciences is a sure-shot tonic for profit
Scrip is at Rs 179, taken a massive and good volume + price breakout on Monday 3rd April 2017.
After complete bottoming out, scrip has taken firm support on 200W EMA between Feb 2016 to March 2017 and is now promising to break out decisively upwards.
Once it crosses 186~187, the momentum will be good.
Fundamentally, the balance sheet is sound, debt free and growing.
Expect price to double within a year.
Buy with a stoploss of Rs 168~161.
After complete bottoming out, scrip has taken firm support on 200W EMA between Feb 2016 to March 2017 and is now promising to break out decisively upwards.
Once it crosses 186~187, the momentum will be good.
Fundamentally, the balance sheet is sound, debt free and growing.
Expect price to double within a year.
Buy with a stoploss of Rs 168~161.
면책사항
이 정보와 게시물은 TradingView에서 제공하거나 보증하는 금융, 투자, 거래 또는 기타 유형의 조언이나 권고 사항을 의미하거나 구성하지 않습니다. 자세한 내용은 이용 약관을 참고하세요.